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SUMMARY
Post-natal skeletal stem cells expressing PRX1 (pnPRX1+) have been identified in the calvaria and in the axial skeleton. Here we charac-
terize the location and functional capacity of the calvarial pnPRX1+ cells.We found that pnPRX1+ reside exclusively in the calvarial suture
niche and decrease in number with age. They are distinct from preosteoblasts and osteoblasts of the sutures, respond to WNT signaling
in vitro and in vivo by differentiating into osteoblasts, and, upon heterotopic transplantation, are able to regenerate bone. Diphtheria
toxin A (DTA)-mediated lineage ablation of pnPRX1+ cells and suturectomy perturb regeneration of calvarial bone defects and confirm
that pnPRX1+ cells of the sutures are required for bone regeneration. Orthotopic transplantation of sutures with traceable pnPRX1+ cells
into wild-type animals shows that pnPRX1+ cells of the suture contribute to calvarial bone defect regeneration. DTA-mediated lineage
ablation of pnPRX1+ does not, however, interfere with calvarial development.
INTRODUCTION
The cranial vault undergoes intramembranous bone forma-
tion and provides mechanical support and protection for
the brain. Important elements of the calvarial structure are
the sutures that narrow during appositional bone growth
and remain as an active site of bone formation during calva-
rial development. In 2007, Lana-Elola et al. showed that
during calvarial development, mesenchymal cells of the
sutures differentiate to form calvarial bone and their
differential fate depends on positioning, with cells occu-
pying the midline of the suture mesenchyme less prone to
differentiation. In2014,Ouyang et al. publisheda thorough
observation about PRX1-expressing cells of the postnatal
calvaria, showing that these cells have qualities of skeletal
stem cells (SSCs), reside in the calvarial sutures, and are
distinct from postnatal cells of the sutures expressing
Collagen 1 (COL1). Zhao et al. (2015) and, more recently,
Maruyama et al. (2016) showed that various populations
of SSCs reside in postnatal calvarial sutures, supporting
the logic that the stem cell niche of the calvaria is
contained in the suture mesenchyme. Additional research
about SSCs of the calvaria and their niche is required to
devise therapeutic strategies which, by targeting a specific
population of SSCs, can promote calvarial bone regenera-
tion or perturb the development of craniofacial malforma-
tions, such as craniosynostosis.
The pair-related homeobox gene Prx1 (also known as
Prrx1) is a transcription factor that is highly expressed dur-
ing limb bud formation and craniofacial development
(Martin and Olson, 2000). PRX1-expressing cells and their
postnatal progeny also have a central role in bone homeo-
stasis and fracture repair since inactivation of RANKL (re-
ceptor activator of nuclear factor kB ligand) expression
in these cells causes osteopetrosis (Xiong et al., 2011)
and inactivation of BMP2 (bone morphogenetic protein
2) expression generates a low-bone-mass phenotype,
with bones prone to factures and unable to repair (Tsuji
et al., 2006). In culture, PRX1-expressing cells isolated
from the periosteum of postnatal long bones (Kawanami
et al., 2009) or postnatal calvaria (Ouyang et al., 2014)
can differentiate into chondroblasts and osteoblasts
upon induction. Additional studies show that PRX1 averts
differentiation of cells into committed osteoblasts (Lu
et al., 2011) or adipocytes (Du et al., 2013). Together, the
evidence suggests that expression of Prx1 is a unique
marker to identify and characterize SSCs of the calvarial
bones. We therefore hypothesize that postnatal cells ex-
pressing PRX1 (pnPRX1+) of the calvaria represent an
SSC population that resides exclusively in the sutures
and is required for calvarial bone regeneration. Using
intravital microscopy (IVM) (Lo Celso et al., 2009), we per-
formed lineage-tracing analyses and lineage-ablation ana-
lyses to show that pnPRX1+ cells reside exclusively in
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the sutures, are required for regeneration of calvarial bone
defects, and are dispensable for postnatal calvarial
development.
RESULTS
pnPRX1+ Cells of the Calvaria Reside in Calvarial
Sutures and Decrease in Number with Age
Prx1-creER-EGFP transgenic mice expressing GFP (EGFP)
under the control of the Prx1 promoter (Kawanami et al.,
2009) were imaged by IVM (Lo Celso et al., 2009) to inves-
tigate the presence of pnPRX1+ cells in calvarial bone and
calvarial sutures.
We found pnPRX1+ cells located exclusively in the
posterior frontal, coronal, sagittal, and lambdoid sutures
(Figure 1A). pnPRX1+ cells were not found in other
craniofacial sutures (Figure 1B), the calvarial periosteum,
or the dura mater (Figure S1). In addition, pnPRX1+ cells
were not present in the calvarial bone marrow of
mature mice (Figure 1Ca), where postnatal osteoblasts ex-
pressing COL1 (Kern et al., 2001) (pnCOL1+ cells) are
commonly found (Figure 1Cb). Within the coronal
suture, pnPRX1+ cells were quantified at 8, 16, 24, and
32 weeks of age and data analysis showed a 75% reduction
of cells between 8 and 32-week-old animals (Figure 1D).
We also quantified the total cellularity of the suture
to determine whether there was a reduction in cell
density and found no difference in total cell numbers
between 8- and 32-week-old animals (Figure S2). These
data confirm that pnPRX1+ cells distinctively populate
the calvarial sutures and that their number decreases
with age.
pnPRX1+ Cells of the Calvarial Sutures Are Distinct
from Preosteoblasts and Osteoblasts of the Calvaria
Given the localization of pnPRX1+ cells, we hypothesized
that they are distinct from postnatal preosteoblasts ex-
pressing Osterix (pnOSX+ cells) (Nakashima et al., 2002).
To test this hypothesis, we imaged Prx1-creER-EGFP
mice crossed with Osterix_mCherry reporter mice
(Strecker et al., 2013). Our data reveal that pnPRX1+ cells
do not co-express OSX in the calvarial sutures (Figure 1Ea).
Consistent with Ouyang et al. (2014), pnPRX1+ cells
are also distinct from postnatal osteoblasts expressing
COL1 (pnCOL1+ cells [Kalajzic et al., 2002; Kern et al.,
2001]). In fact, pnCOL1+ cells were detected by the
osteogenic fronts of the sutures but were never found
within the suture space mesenchyme (Figure 1Eb). We
conclude that pnPRX1+ cells of the calvarial sutures
are distinct from preosteoblasts and osteoblasts of the
calvaria.
PRX1-Expressing Cells and Their Progeny Are
Responsible for the Development of the Calvarial
Sutures and Calvarial Bones, and for Regeneration of
the Calvarial Bones
We performed lineage-tracing analysis to determine
whether PRX1-expressing cells and their progeny are
responsible for the development of calvarial sutures. To
this end, Prx1-Cre mice (Logan et al., 2002) were crossed
with fl/fl tdTOMATO reporter mice (tdTOMATO mice)
(Madisen et al., 2010). Coronal sutures were imaged by
IVM and tdTOMATO was detected in the suture space,
the surrounding periosteum, osteogenic fronts of the
suture, and mature bone (as osteocytes) of both neural
crest-derived (frontal) (Jiang et al., 2002) and mesoderm-
derived (parietal) (Yen et al., 2010) bones of Prx1-
cre+/;tdTOMATO+/ mice (Figure 2A). To confirm the
results, we crossed the Prx1-Cre mice with transgenic
mice able to express diphtheria toxin A (DTA) upon CRE
recombination of a loxP-flanked STOP cassette (Voehringer
et al., 2008). The Prx1-cre+/;DTA+/ mice at birth (post-
natal day 0 [P0]) displayed incomplete development of
the frontal bone and lack of development of the parietal,
interparietal, and occipital bones (Figure 2Ba). The poste-
rior frontal, coronal, sagittal, and lambdoid sutures were
also absent. Gross anatomical inspection revealed impaired
limb development in these mice (Figure 2Bb) and validated
our experimental approach, since PRX1 is also expressed in
developing limbs (Logan et al., 2002).
These lineage-tracing and lineage-ablation analyses
indicate that embryonic cells expressing PRX1, their post-
natal progeny, and, possibly, postnatal cells expressing
PRX1 cells are responsible for development of neural
crest-derived (i.e., frontal bone) (Jiang et al., 2002) and
mesoderm-derived (i.e., parietal bone) (Yen et al., 2010)
calvarial bones. Thus, expression of PRX1 identifies a
population of cells of mixed neural crest and mesoderm
origins.
To test whether PRX1-expressing cells and their prog-
eny also regenerate calvarial bones, we evaluated their
contribution to regeneration of a subcritical defect (Cowan
et al., 2004) in the frontal and parietal bones of 8-week-
old Prx1-cre+/;tdTOMATO+/ animals (Figure 2C). IVM
analysis of the regenerated bones shows cells expressing
tdTOMATO in the defects 5 days post surgery, increased
progeny 10 days post surgery, and in bone formed
30 days post surgery.We concluded that progeny of embry-
onic cells expressing PRX1 and possibly pnPRX1+ cells
contribute to the regeneration of neural crest-derived (fron-
tal) (Jiang et al., 2002) and mesoderm-derived (parietal)
(Yen et al., 2010) calvarial bones. Thus, postnatal expres-
sion of PRX1 may identify a population of cells that
contribute to or are directly responsible for calvarial bone
regeneration.
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Figure 1. pnPRX1+ Cells of the Calvaria Are Found in the Calvarial Sutures, Decline in Number with Age, and Are Distinct from
Preosteoblasts and Osteoblasts
(A) Visualization of EGFP-expressing cells in calvarial sutures of PRX1-creER-EGFP+/ mice, at different ages.
(B) Visualization of EGFP-expressing cells in other craniofacial sutures of PRX1-creER-EGFP+/mice in 2-week-old animals. Coronal sutures
were used as control (ctrl).
(C) (a) Intravital examination of the calvarial bone marrow space (BM) in 8-week-old Prx1-creER-EGFP+/ mice. Dashed lines demarcate
the suture space. (b) Intravital examination of the calvarial bone marrow space in 8-week-old Col1-EGFP+/ mice.
(D) Quantification of EGFP-expressing cells (pnPRX1+ cells) in coronal sutures of Prx1-creER-EGFP+/mice at different ages (n = 3–5 mice/
group). The average number of cells/mm3 ± SD are reported.
(E) Visualization of EGFP-expressing cells and mCherry-expressing cells in the coronal suture of 2-week-old Prx1-creER-EGFP+/;Osx-
mCherry+/ mice. OSX is expressed in osteocytes (yellow arrowheads), cells at the osteogenic front (white arrowheads), and a few cells in
the suture (red arrowheads). Unlike Prx1-expressing cells in the suture, Col1-EGFP-expressing cells are only expressed in osteocytes (yellow
arrowheads) and cells at the osteogenic front (white arrowheads). Dashed lines demarcate the suture space.
Scale bars, 50 mm.
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Figure 2. PRX1-Expressing Cells and Their Progeny Are Responsible for the Development of the Calvarial Sutures and Calvarial
Bones, and for the Regeneration of the Calvarial Bones
(A) Lineage-tracing analysis of PRX1-expressing cells of the coronal suture in 6- to 8-week-old PRX1-cre+/;tdTOMATO+/mice (transversal
sections at 0, 20, 40, and 80 mm from the periosteal surface). Bone is visualized by second harmonic generation (blue). Frontal bone
(F), parietal bone (P), suture space (yellow double arrow), osteogenic fronts (white arrows), and osteocytes (white arrowhead) are
indicated (n = 3 mice).
(B) Effects of global ablation of Prx1+ cells during embryogenesis in newborn (P0) Prx1-cre;DTA mice. (a) Calvarial bones. (b) Forelimb
(black arrowheads) and hindlimb (white arrowheads) (n = 4–6 mice/group).
(C) Lineage-tracing analysis of the PRX1-expressing cells of the neural crest-derived frontal (F) and mesoderm-derived parietal (P) bones
during bone regeneration in 8-week-old PRX1-cre+/;tdTOMATO+/ mice. Images were acquired at the time of the defect creation (t0),
5 days later (t5), 10 days later (t10), and 30 days later (t30) to show Prx1 progeny migrating into the defect (white dotted lines) and
forming new bones as osteocytes (white arrows) (n = 3 mice).
Scale bars, 50 mm.
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pnPRX1+-Expressing Cells of the Calvaria Are
Required for Calvarial Bone Regeneration
To determine whether pnPRX1+ cells of the sutures can
mediate bone regeneration, we transplanted coronal su-
tures obtained from Prx1-creER-EGFP+/;tdTOMATO+/
mice into a critical-size calvarial bone defect (2 mm
in diameter) (Cowan et al., 2004) of wild-type mice
(C57BL/6) (heterotopic transplantation, Figure 3A). Wild-
type hosts were then injected with tamoxifen to induce
tdTOMATO expression in the progeny of the transplanted
pnPRX1+ cells within the newly regenerated bone. Results
show that transplanted suture tissue (heterotopic site) is
able to regenerate bone rather than suture-like struc-
tures and that pnPRX1+ cells of the sutures give rise to
the majority of the cells incorporated into the newly
formed bone.
Figure 3. pnPRX1+ Cells of the Calvaria
Can Regenerate Bone and Are Required
for Calvarial Bone Regeneration, and Cal-
varial Sutures Are Their Exclusive Niche
(A) Lineage-tracing analysis of pnPRX1+
cells upon heterotopic transplantation
of minced sutures from Prx1-creER-
EGFP+/;tdTOMATO+/ mice into critical-
size calvarial bone defects created in wild-
type mice (C57BL/6). Bone defects are
identified by the red dashed lines (n = 2–3
mice/group). Scale bars, 100 mm.
(B) Micro-computed tomography and
histological sections of calvarial bones
dissected 28 days after subcritical calvarial
defect surgery (0.5 mm in diameter) in the
presence (left) (mice treated with tamox-
ifen but not carrying the DTA transgene) and
absence (right) (mice treated with tamox-
ifen and carrying the DTA transgene)
of pnPRX1+ cells. Dashed lines demarcate
the calvarial subcritical bone defect (n = 6
mice). Histology scale bars, 100 mm.
(C) Interval Lineage-tracing analysis of
pnPRX1+ cells in defect healing (100 mm in
diameter, white dotted lines) using 8-week-
old PRX1-creER+/;tdTOMATO+/ mice. Im-
ages acquired at the time of defect creation
(t0), five days later (t5), 10 days later (t10)
(n = 6 mice), and 60 days later (t60) (n = 2
mice). Scale bars, 50 mm.
(D) (Upper) Suturectomy of the frontal and
left coronal sutures (thick red lines) with a
subcritical bone defect created in the right
parietal bone. (Lower) Suturectomy of the
sagittal and right coronal sutures (thick red
lines) with a subcritical bone defect created
in the right parietal bone. Thin red lines
across the defects indicate the sagittal
planes of the histological sections shown.
Black dashed lines in the histological sections indicate suturectomy sites and regeneration sites (n = 5 mice/group).
(E) Lineage-tracing analysis of pnPRX1+ cells upon orthotopic transplantation of coronal and sagittal sutures from Prx1-creER-
EGFP+/;tdTOMATO+/ mice into suturectomy sites of wild-type mice (C57BL/6). (Upper left) Orthotopic transplantation of the coronal
and sagittal sutures (yellow arrows). (Upper right) Day 7 post parietal, subcritical bone defect surgery (horizontal views at 60 mm from the
periosteal surface). Red arrows point to tdTOMATO-expressing cells detected in the defect. Scale bars, 100 mm. (Lower) Day 14 post defect
surgery. Horizontal rendering of the transplanted suture (TS, white dashed lines) and the bone defect (white dotted circle). Blue and red
signals are shown in maximum-intensity projection over 20 mm of depth (n = 2 mice). Scale bars, 100 mm (upper) and 500 mm (lower).
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To expand on the data, we used Prx1-CreEr-EGFP+/;
DTA+/ mice to conditionally ablate pnPRX1+ cells during
bone regeneration. Preliminary tests showed that 5 days
of tamoxifen treatment in these mice results in >80%
pnPRX1+ cell ablation efficiency (Figure S3). We observed
that in a subcritical calvarial bone defect model (0.5 mm
in diameter), 8- to 10-week-old Prx1-creER-EGFP+/;DTA+/
mice treated with tamoxifen showed that ablation of
pnPRX1+ cells impairs regeneration of the defects (Fig-
ure 3B). Using IVM,we further demonstrated that pnPRX1+
cells directly contribute to bone regeneration of the
subcritical calvarial defect in 8-week-old Prx1-creER-
EGFP+/;tdTOMATO+/ mice (Figure 3C), where pnPRX1+
cells (EGFP+) and their progeny (tdTOMATO+) migrated
into the defects by day 10 after the defect was made. We
concluded that pnPRX1+ cells are required to regenerate
calvarial bone. However, since DTA globally ablates
pnPRX1+ cells, further studies are necessary to isolate the
contributions of pnPRX1+ cells specifically localized to
the calvarial sutures in regeneration of calvarial defects.
The Calvarial Suture Is the Exclusive Niche of the
pnPRX1+ Cells
To confirm that only the pnPRX1+ cells of the calvarial su-
tures contribute to the regeneration of calvarial defects and
therefore that the calvarial suture is their exclusive niche,
we isolated the contribution of other potential sources of
pnPRX1+ cells. First, we created a subcritical calvarial defect
in the parietal bone of the calvaria while concomitantly
performing suturectomy (without affecting the underlying
dura). Previously we showed that parietal bone defects are
unable to heal if a suturectomy of the surrounding coronal
and sagittal sutures is performed concomitantly to the
creation of the defect. The results demonstrate that subcrit-
ical-size bone defects are unable to heal in absence
of surrounding intact sutures (Figure 3D). In a second
Figure 4. pnPRX1+ Cells of the Calvaria Present with Qualities of Skeletal Stem Cells
(A) In vitro, pnPRX1+ cells (EGFP+) and EGFP cells isolated from the calvarial sutures of 4-week-old Prx1-creER-EGFP+/mice were cultured
at 1 cell/well in a 96-well plate. Colony-forming units (CFU) were counted after 3 weeks and the average CFU/experiment ± SD are reported
(n = 3 independent experiments). **p < 0.01. The inset shows the colony formed by the pnPRX1+ cells. Scale bar, 200 mm.
(B) Ex vivo qRT-PCR analysis of pnPRX1+ cells (GFP+) and EGFP cells isolated from the calvarial sutures of 4-week-old Prx1-creER-EGFP+/
mice (n = 3 independent experiments). *p < 0.05, **p < 0.01. EGFP+ and EGFP validation screen shows higher levels of expression of both
transcriptional variants of Prx1 detected in EGFP+ cells. Relative expression values ± SD are reported.
(C) Osteodifferentiation of pnPRX1+ cells 48 hr after treatment with rmWNT3a in vitro (n = 3 independent experiments). Relative
expression values ± SD are reported. *p < 0.05, **p < 0.01.
(D) Osteodifferentiation of pnPRX1+ cells 24 hr after treatment with rmWNT3a in vivo (n = 5–6 mice/group). Relative expression values ±
SD are reported. *p < 0.05, **p < 0.01.
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experiment, we transplanted the sagittal and right coronal
suture from Prx1-creER-EGFP+/;tdTOMATO+/ mice into
wild-type mice (orthotopic transplantation, Figure 3E).
Six weeks after transplantation, host mice (wild-type)
were treated with tamoxifen and a subcritical-size defect
was created in the parietal bone surrounded by the trans-
planted sutures. IVM analysis showed that progeny of the
transplanted pnPRX1+ cells (tdTOMATO+) appear within
the deepest portion of the parietal defect 7 days after sur-
gery. Fourteen days after surgery, we saw progeny of the
transplanted pnPRX1+ cells incorporated in the newly re-
generated bone and in the nearby tissue. tdTOMATO-ex-
pressing cells were not seen in the contralateral parietal
bone. Therefore, since a regional suturectomy averts bone
regeneration and pnPRX1+ cells of orthotopically trans-
planted sutures contribute to bone regeneration, we can
conclude that pnPRX1+ cells of the sutures are the PRX1-
expressing cells required for intramembranous bone regen-
eration and that the calvarial suture is their exclusive niche.
pnPRX1+ Cells of the Calvarial Sutures Present with
Qualities of Skeletal Stem Cells
To characterize pnPRX1+ cells as SSC’s, we first performed
in vitro clonogenic assays and confirmed that pnPRX1+
cells isolated from the calvarial sutures of 4-week-old
Prx1-creER-EGFP+/ mice are clonogenic (Figure 4A).
Ex vivo gene expression analysis of pnPRX1+ cells
(EGFP+) and EGFP cells isolated from calvarial sutures of
4-week-old Prx1-creER-EGFP+/ mice (Figure 4B; Table 1)
supports that EGFP+ cells present with a well-defined
SSC profile. We observed an upregulation of Pdgfra and
Mcam/Cd146, two genes associated with SSCs (Chan
et al., 2015; Houlihan et al., 2012; Pinho et al., 2013; Sac-
chetti et al., 2007). pnPRX1+ cells also express low levels
of genes associated with cell cycle progression, chromo-
some segregation, and DNA replication such as Ccne2,
Mcm4, and Pcna which are characteristic of quiescent cells
(Cheung and Rando, 2013). Higher levels of Itga2, Itga3,
and Itga6 genes associated with stem cell homing and
anchoring to the extracellular matrix of the niches (Chen
et al., 2013; Cheung and Rando, 2013) were also detected
in pnPRX1+ cells. Finally, pnPRX1+ cells express high levels
of Dkk1 and Sost, two inhibitors of the WNT signaling
pathway (Baron and Kneissel, 2013) that are suggested to
contribute to the maintenance of the undifferentiated
quiescent status of the pnPRX1+ cells.
Canonical WNT signaling is significantly active during
craniofacial bone formation (Mani et al., 2010). There-
fore, to test the differentiation potential of pnPRX1+ cells,
we stimulated pnPRX1+ cells cultured in vitro with re-
combinant mouse WNT3a (rmWNT3a) for 48 hr and
found an increase in the expression of osteoblast-specific
markers and reduction in the expression of Sox9, a well-
defined chondroblastic marker (Figure 4C; Table 1). To
confirm this finding, we injected rmWNT3a locally to cal-
varial sutures of Prx1-creER-EGFP+/ mice and found that
pnPRX1+ cells isolated 24 hr after treatment presented the
same gene expression variations observed in pnPRX1+
cells treated in vitro (Figure 4D; Table 1). Validation of
the subperiosteal local injection was confirmed by IVM
(Figure S4).
The qualities of pnPRX1+ cells, typically seen in SSCs,
support our hypothesis that pnPRX1+ cells represent a
quiescent population of cells of the sutures that upon
appropriate stimulation (i.e., a WNT canonical agonist)
can exit the undifferentiated status and differentiate into
osteoblasts.
In the Postnatal Suture, PRX1-Expressing Cells
Overlap with GLI1-Expressing Cells
In adult mice, GLI1 marks the vast majority of the suture
mesenchyme with the exception of few cells at the
osteogenic fronts (Zhao et al., 2015). Our model shows
Table 1. qRT-PCR TaqMan Gene Expression Primer Assay Codes
Gene TaqMan Assay Code
TBP Mm00446971_m1
Tubb5 Mm00495806_g1
B-actin Mm02619580_g1
Prx1 V1 Mm00599934_m1
Prx1 V2 Mm01014477_m1
Col2a1 Mm01309565_m1
Sox9 Mm00448840_m1
Mcam/Cd146 Mm00522397_m1
Dkk1 Mm00438422_m1
Axin2 Mm00443610_m1
Col1A1 Mm00801666_g1
Osx/Sp7 Mm04209856_m1
Sost Sclerostin Mm04208528_m1
Gli1 Mm00494654_m1
Pdgfr alpha Mm00440701_m1
CCNE2 Mm00438077_m1
MCM4 Mm00725863_s1
PCNA Mm00448100_g1
Itga2 Mm00434371_m1
Itga3 Mm00442910_m1
Itga6 Mm00434375_m1
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that pnPRX1+ cells occupy a more discrete position
within the suture space (Figure 1). To confirm this dif-
ferential localization, we compared the expression of
tdTOMATO in short-pulsed 4-week-old Prx1-creER-
EGFP+/;tdTOMATO+/ mice and in short-pulsed 4-week-
old Gli1-creER+/;tdTOMATO+/ mice. Results indicate
that GLI1 expression marks a wider population of cells
within the sutural space (Figure 5A). Quantification of
the percentage of cells of the Prx1-creER-EGFP+/;
tdTOMATO+/ suture expressing tdTOMATO after short-
pulsing of tamoxifen confirms that this difference is not
due to a lower recombination efficiency of the Prx1-
creER-EGFP transgene (Figure S5). Furthermore, in situ hy-
bridization confirms that expression of endogenous Prx1 is
recapitulated by the expression of the Prx1-creER-EGFP
transgene (Figure S6).We then hypothesized that pnPRX1+
cells also express Gli1. Ex vivo qRT-PCR of the EGFP+ cells
and EGFP cells isolated from the coronal and sagittal su-
tures of Prx1-creER-EGFP+/mice shows that pnPRX1+ cells
(EGFP+) express higher levels ofGli1 compared with EGFP
cells of the suture (Figure 5B; Table 1). These data indicate
that there is an overlap between pnGLI1+ and pnPRX1+
cell populations, with PRX1 expressed in a smaller number
of cells within the suture.
Maruyama et al. (2016) showed that there is also an
overlap between the AXIN2-expressing cells of the su-
tures (pnAXIN2+) and the pnGLI1+ cells therefore we
investigated whether pnPRX1+ cells and pnAXIN2+ cells
are the same stem cell population of the suture. Ex vivo
quantitative gene expression analysis reveals no dif-
ference in Axin2 expression levels in pnPRX1+ cells
compared with the expression levels measured in
the entire EGFP population of the suture (Figure 5B;
Table 1). This indicates that expression of Axin2 in
pnPRX1+ cells is low. In support of this evidence, we
found that expression of Axin2 is lower in pnPRX1+ cells
compared with mature osteoblasts of the suture express-
ing COL1 (pnCOL1+ cells of the sutures) (Figure 5B).
Since upregulation of Axin2 is reported to be induced
by agonists of WNT signaling (Baron and Kneissel,
2013), we tested whether the expression levels of Axin2
in pnPRX1+ cells could be increased by rmWNT3a.
Data show that pnPRX1+ cells treated with rmWNT3a
in vitro increases Axin2 expression by 5-fold (Fig-
ure 5C; Table 1). This WNT-specific responsiveness was
confirmed by the observed inhibition of Axin2 expres-
sion upon co-treatment with recombinant DKK1 (Fig-
ure 5C). In vivo, we found that subperiosteal delivery
Figure 5. In the Postnatal Suture, PRX1-Expressing Cells Overlap with GLI1-Expressing Cells
(A) Comparative evaluation of tdTOMATO expression in 4-week-old Prx1-creER-EGFP+/;tdTOMATO+/ and Gli1-creER+/;
tdTOMATO+/ mice treated with tamoxifen for 5 days (short-pulsing). S, suture space (n = 2 mice). Scale bars, 100 mm.
(B) Ex vivo qRT-PCR analysis of Gli1 and Axin2 expression in pnPRX1+ cells (EGFP+), (EGFP), and in pnCOL1+ cells isolated from the sutures
(n = 3 independent experiments). Relative expression values ± SD are reported. **p < 0.01.
(C) In vitro qRT-PCR analysis of Axin2 expression in cells treated with rmWNT3a and rmDKK1 (n = 3 independent experiments). Relative
expression values ± SD are reported. **p < 0.01.
(D) In vivo qRT-PCR analysis of Axin2 expression in pnPRX1+ cells treated with rmWNT3a (n = 5–6mice/group). Relative expression values ±
SD are reported. **p < 0.01.
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Figure 6. pnPRX1+ Cell Ablation in Young Mice Does Not Interfere with Calvarial Development
(A) Global ablation of pnPRX1+ cells in P28 Prx1-creER-EGFP;DTA mice. (Left) mCT rendering (top) and histological sagittal sections of the
coronal sutures (bottom). (Right) Measurements of calvaria, femur, and tibia (n = 4–7 mice/group). Average measurements in mm ± SD are
reported. *p < 0.05, **p < 0.01.
(B) Global ablation of pnPRX1+ cells in P7 Prx1-creER-EGFP; DTA mice. (Left) mCT rendering (top) and histological sagittal sections of the
coronal sutures (bottom). (Right) measurements of calvaria, femur, and tibia (n = 2–3 mice/group). Average measurements in mm ± SD are
reported.
(C) Healing of subcritical defects 2 months after global ablation of pnPRX1+ cells in P28 animals. mCT and histology 28 days after creation
of the defect (n = 2 mice/group). Scale bar, 100 mm.
(D) pnPRX1+ cells (left) and pnGLI1+ cells (right) in mandibular bones of Prx1-creER-EGFP+/;tdTOMATO+/ mice and Gli1-creER+/;
tdTOMATO+/ mice, respectively (short-pulsing with tamoxifen for 5 days). Phase-contrast images are shown to facilitate anatomical
localization. M, molar teeth; I, incisor tooth (n = 2 mice). Histology scale bars, 100 mm.
Stem Cell Reports j Vol. 8 j 933–946 j April 11, 2017 941
of rmWNT3a by the calvarial sutures induces osteodiffer-
entiation of pnPRX1+ cells (Figure 4D) and overexpres-
sion of Axin2 in pnPRX1+ cells (Figure 5D; Table 1). We
conclude that pnPRX1+ cells represent a cell population
with basal levels of expression of AXIN2 and are able to
overexpress AXIN2 upon WNT agonist stimulation.
pnPRX1+ Cells of the Suture Are Dispensable for
Postnatal Calvarial Development
Previous studies reported that global ablation of pnGLI1+
cells in 4-week-old mice averts craniofacial growth and
induces craniosynostosis (Zhao et al., 2015). Since the
pnPRX1+ and the pnGLI1+ cell populations of the suture
overlap in adult mice and pnPRX1+ cells represent a
smaller cell population than pnGLI1+ cells, we hypothe-
sized that ablation of pnPRX1+ cells in 4-week-old mice
would generate a less significant phenotype than the
one obtained by Zhao et al. We ablated pnPRX1+ cells
in P28 Prx1-creER-EGFP+/;DTA+/ mice and analyzed
the phenotype of their calvaria and long bones 8 weeks
after ablation. Our results show no significant craniofa-
cial phenotype in ablated pnPRX1+ cells of these mice
(Figure 6A). Only changes in the length of the femur
and the tibia presented a statistically significant differ-
ence (Figure 6A). When we ablated pnPRX1+ cells in P7
Prx1-creER-EGFP+/;DTA+/ mice, we observed a similar
trend (Figure 6B). Global ablation of pnPRX1+ cells at
P28 has a significant effect on the length of the long
bones, suggesting that either a significant pool of
pnPRX1+ is still needed for development of postnatal
long bones or that pnPRX1+ cells have a different role
in endochondral bone formation and elongation. Never-
theless, in the calvaria, results differ from the effects
observed upon ablation of the widely present pnGLI1+
cells, which results in skull growth arrest and craniosy-
nostosis (Zhao et al., 2015). We show that pnPRX1+ are
necessary for subcritical calvarial bone defect regen-
eration (Figure 6C) and are dispensable for calvarial
development.
Since ablation of pnPRX1+ cells has no developmental
effects on craniofacial development, we also hypothe-
sized that the distribution of the pnPRX1+ cells across
craniofacial tissues is limited. Results of our investiga-
tion in tamoxifen short-pulsed 4-week-old Prx1-creER-
EGFP+/;tdTOMATO+/ mice support our hypothesis and
show that pnPRX1+ cells expressing tdTOMATO are spe-
cifically associated only with continuously regenerating
tissues, such as the incisor (Zegarelli, 1944; Figure 6D,
left). Using the same short-pulsing strategy in 4-week-
old Gli1-creER+/;tdTOMATO+/ mice, we identified
pnGLI1+ cells in the incisor and in other more metaboli-
cally stable tissues, such the molars and the mandibular
bone (Figure 6D, right), indicating that Prx1 expression
is more restricted than Gli1 expression in craniofacial
tissues.
DISCUSSION
In this work, we confirm that pnPRX1+ cells of the
calvaria presented gene expression profiles of SSC’s, are
localized to the calvarial suture niche, and are required
for calvarial bone regeneration. Global ablation strategies
of SSCs do not allow to unequivocally conclude that
individual locations (i.e., the sutures) represent their
unique niches because absence of the cells from other
locations may be responsible for the observed effects.
We evaluated the contribution of pnPRX1+ cells of the
sutures to calvarial bone regeneration in three different
settings (global ablation, regional suturectomy, and or-
thotopic suture transplantation). This triple experi-
mental strategy allowed us to confirm that sutures are
the exclusive niches of the calvarial SSCs expressing
PRX1.
Our work demonstrates that expression of PRX1 iden-
tifies a subpopulation of the pnGLI1+ cells identified
by Zhao et al. (2015). Interestingly, global ablation of
pnPRX1+ cells does not result in a major developmental
phenotype whereas global ablation of pnGLI1+ cells averts
craniofacial growth and induces craniosynostosis. This
is expected for two reasons: First, pnPRX1+ cells are
discretely distributed across the suture space and their
ablation should therefore generate a phenotype less sig-
nificant than the one obtained by ablation of the widely
distributed pnGLI1+ cells. Second, preosteoblasts and oste-
oblasts of the calvaria have life spans longer than 60 days
(Park et al., 2012) and represent a reservoir of cells able to
form bone even in absence of their progenitors (in our
case pnPRX1+ cells). Thus, the effects of the ablation of
SSCs should be seen in long-term studies and may influ-
ence craniofacial development only if ablation is per-
formed early enough during development, when a signif-
icant pool of SSCs is required. Indeed, when global
ablation of PRX1-expressing cells is performed during
embryogenesis, we observe an incomplete calvarial bone
formation.
Maruyama et al. (2016) did not perform global ablation
studies of pnAXIN2+ cells. However, the fact that postnatal
OSTERIX-expressing cells co-express AXIN2 (Tan et al.,
2014) and the fact that Osx is expressed in preosteoblasts
(Nakashima et al., 2002; Strecker et al., 2013) suggests
that ablation of pnAXIN2+ cells could generate a more sig-
nificant development phenotype than the one observed
in the pnPRX1+ cell ablation studies. Although gene
knockout studies cannot be correlated to ablation studies
of cells expressing the same genes, the fact that knockout
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of Axin2 generates premature suture closing and craniosy-
nostosis (Yu et al., 2005) suggests that this may in fact be
the case.
Our studies indicate that pnPRX1+ cells express low levels
of Axin2 and that these levels increase upon WNT agonist
stimulation. This result may indicate that either pnPRX1+
cells are the same cells identified by Maruyama et al.
(pnAXIN2+ cells) or that pnPRX1+ cells are a subpopulation
of pnAXIN2+ cells. Since, at least in long bones, the major-
ity of the postnatal bone cells expressing OSX co-express
AXIN2 (Tan et al., 2014), pnPRX1+ cells differ from the
OSX-expressing cells of the suture (Figure 1E), and ablation
of pnPRX1+ does not interfere with postnatal calvarial
development, we speculate that pnPRX1+ cells are a sub-
population of the pnAXIN2+ cells identified by Maruyama
et al. Additional studies are required to test this postulation.
In conclusion, our studies showed that pnPRX1+ cells are
responsible for calvarial bone regeneration and represent
an initial step toward future investigations aiming to iden-
tify novel, effective therapies for calvarial malformations
and defects.
EXPERIMENTAL PROCEDURES
Animals
Experiments were conducted in compliance with the Guide for
the Care and Use of Laboratory Animals (IACUC approval
IS00000535). The transgenic mouse lines studied include Prx1-cre
mice, Prx1-creER-EGFPmice, Col1-EGFPmice, Osx-mCherrymice,
Rosa26LoxP-STOP-loxP-tdtomato (in this study named tdTOMATO
mice), and Rosa26LoxP-STOP-loxP-DTA (in this study named DTA
mice). Only male mice were utilized throughout the reported
in vivo studies.
Intravital Microscopy
IVM was performed as previously described (Lo Celso et al., 2009).
The excitation beam is focused into the sample plane using a 603
objective lens (numerical aperture = 1). Fluorescence emission is
then collected by either confocal or two-photon detectors with
proper dichroic and filter settings corresponding to fluorophores
of interest. EGFP signals are detected with a 525/38-nm bandpass
filter using either two-photon or confocal acquisition excited
by a 491-nm laser (Cobolt Calypso). Prx1 progeny expressing
tdTOMATO are excited by a Ti:Sapphire laser at 750 nm and
detected with a 625/50-nm bandpass filter. Confocal acquisition
of Osx-mCherry cells are excited by a 561-nm laser (Cobolt Jive)
and detected using a 695/55-nm bandpass filter. For visualization
of bones, second harmonic generation (SHG) of collagen is excited
by the Ti:Sapphire laser pulsing between 840 and 900 nm accord-
ing to experimental requirement, and collected by a 435/40-nm
bandpass filter.
For visualization of cell distribution in depth, stack images at
1- to 5-mm intervals were acquired via two-photon acquisition.
Two-dimensional sections were processed by the reslice function
of ImageJ.
Quantification of PRX1-Expressing Cells of the
Coronal Sutures
Quantification of the PRX1-expressing cells was performed as pre-
viously described (Lo Celso et al., 2009) (n = 3–5 mice per time
point).
Constitutive Lineage-Tracing Studies
Prx1-cre+/ male mice were crossed with tdTOMATO+/+ female
mice. The Prx1Cre+/;tdTOMATO+/ male mice were analyzed by
IVM at 8 weeks of age (n = 3 mice).
Constitutive Lineage-Ablation Studies
Prx1-cre+/ male mice were crossed with DTA+/+ female mice. P0
mice were collected immediately after birth, skinned, eviscerated,
and fixed in 70%ethanol. An alizarin red/Alcian blue double-stain-
ing solution was used to distinguish calcified bone from cartilage
for Prx1-cre+/;DTA+/ test (n = 4 mice) and Prx1-cre/;DTA+/
controls (n = 6 mice).
Constitutive Lineage-Tracing Studies during Bone
Regeneration
Prx1-cre+/ male mice were crossed with tdTOMATO+/+ female
mice to obtain Prx1-cre+/;tdTOMATO+/ male mice. A 100-mm
defect was created by femtosecond laser ablation in the left frontal
calvaria and right posterior calvaria of 8-week-old male mice. IVM
was used to visualize PRX1-lineage cells at 0, 5, 10, and 30 days
after creation of the defect (n = 3 mice).
Inducible Lineage-Tracing Studies during Heterotopic
Suture Transplantation
Four-week-old Prx1-creER-EGFP+/;tdTOMATO+/ male mice (do-
nors) were euthanized to provide tissue transplants to 4-week-old
wild-type male mice (recipients). Coronal and sagittal sutures
were excised from the donors, chopped into fine chips, mixed
with Matrigel, and stored on ice. Using a drill with a 1-mm
round bur, a 2-mm defect was created carefully (so as not to
damage the underlying dura) in the left and right parietal
bones of the recipient mice. The right defect was filled with
suture chips + Matrigel or with Matrigel only. Animals were
treated with 100 mL of tamoxifen in sterile oil (test, n = 3
mice) or sterile oil only (control, n = 2 mice) for 2 days
(40 mg/kg, intraperitoneally) following surgery and then eutha-
nized on day 28. Calvaria were prepared for histological fluores-
cent analysis.
Inducible Lineage-Ablation Studies during Subcritical
Defect Regeneration
Eight-week-old, male Prx1-creER-EGFP+/;DTA+/ mice (test,
n = 6 mice) and Prx1-creER-EGFP/;DTA+/ mice (control,
n = 6 mice) were injected with tamoxifen (intraperito-
neally, 40 mg/kg in sterile oil) for 5 days before and 5 days
after surgery. A 0.5-mm defect was made in the right parie-
tal bone using a 0.5-mm round bur. Twenty-eight days
after surgery, calvarial samples were fixed in 70% EtOH for
micro-computed tomography (mCT) analysis and histological
processing.
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Inducible Lineage-Tracing Studies during Bone
Regeneration
Eight-week-old,malePrx1-creER-EGFP+/;tdTOMATO+/micewere
injected with tamoxifen (intraperitoneally, 40 mg/kg in sterile oil)
for 3 days before making a 100-mm defect using femtosecond laser
ablation. IVM was performed at the time of the defect creation
(t0), 5days after (t5),10daysafter (t10) (n=6mice), and60days after
(t60) (n = 2 mice).
Suturectomy Studies
Eight-week-old, male Prx1-creER-EGFP+/;tdTOMATO+/ mice
were used. Sutures were disrupted mechanically using a dental
drill with a 0.25-mm diamond bur without perforating the
dura. Bone defects (0.5 mm in diameter) were made 2 mm
away from the sutures. Animals were euthanized 28 days after
surgery and calvaria were dissected for histological processing
(n = 5 mice/group).
Inducible Lineage-Tracing Studies during Orthotopic
Suture Transplantation
Four-week-old, male Prx1-creER-EGFP+/;tdTOMATO+/mice (do-
nors) were euthanized to provide tissue to 4-week-old, male wild-
type mice (recipients). The right coronal and sagittal sutures were
excised from the donors and transplanted into an orthotopic site
in recipient mice (after suturectomy). Six weeks after suture trans-
plantation, a bone defect (0.5 mm in diameter) was made in the
right parietal bone. Animals were injected with tamoxifen (intra-
peritoneally, 40 mg/kg in sterile oil) for 5 consecutive days to
induce lineage tracing, and defects were imaged by IVM at days 7
and 14 postoperatively (n = 2 mice).
Single-Cell Clonogenicity Analysis
Four-week-old Prx1-creER-EGFP+/ mice were euthanized for
EGFP+ cell isolation from coronal and sagittal sutures using
fluorescence-activated cell sorting (FACS). 480 single EGFP+
or EGFP cells were sorted into five 96-well plates and cultured
in basic medium (a-minimum essential medium [aMEM]
supplemented with 20% fetal bovine serum [FBS] and 1% peni-
cillin/streptomycin) for 3 weeks with medium changed
twice per week. Cells were then washed with Earle’s balanced
salt solution, fixed in 3.7% paraformaldehyde, and stained
with crystal violet for CFU-F analysis. Wells with more than
50 cells per colony were counted, (n = 3 independent
experiments).
Ex Vivo qRT-PCR Analysis of PRX1-Expressing Cells
Four-week-old Prx1-creER-EGFP+/ or Col1-EGFP+/ mice were
euthanized for EGFP+ cell isolation from coronal and sagittal su-
tures using FACS. Coronal and sagittal sutures were dissected,
pooled, and digested at 37C in a shaking water bath in two steps.
First, with 3 mg/mL of collagenase II (Worthington Biochemical;
cat. #LS004176) in aMEM and 1% penicillin/streptomycin
for 90 min; then with 0.76 U/mL of collagenase P (Roche; cat.
#11249002001), 0.67 U/mL of dispase (Worthington Biochemical;
cat. #LS02104) in aMEM, and 1% penicillin/streptomycin for
30 min.
EGFP+ and EGFP cells were sorted (average of 10,000). Cell lysis,
RNA isolation, and reverse transcription for gene expression anal-
ysis were performed using the Single Cell to CT kit (Thermo Fisher
Scientific; cat. #4458237). qRT-PCR reactions were carried out
using the TaqMan gene expression analysis technology. TaqMan
assay codes for each gene primer set are listed in Table 1 (n = 3
independent experiments).
WNT Stimulation Studies
For in vitro studies, EGFP+ and EGFP cells were sorted by FACS
from calvaria of newborn animals (n = 5–7 animals) and seeded
into 6-well plates in basic medium (aMEM, 20% FBS, 1%
penicillin/streptomycin) for cell culture. Cells (passage 4) were
treated with either 50 ng/mL of rmWNt3a or 1,000 ng/mL of
rmDDK1 (R&D Systems) and incubated for 48 hr, or pretreated
for 24 hr with 1,000 ng/mL of rmDKK1 (R&D Systems) and
then stimulated with 50 ng/mL of rmWNT3a (R&D Systems)
for 48 hr. qRT-PCR was performed using TaqMan real-time PCR
assays (Life Technologies) (n = 3 independent experiments). For
in vivo studies, 7-day-old Prx1-creER-EGFP+/ animals received
calvarial subperiosteal injections of rmWnt3a (440 ng/day in
PBS, R&D Systems) (n = 6 mice) or control (PBS) (n = 5 mice)
for 2 consecutive days. After 24 hr, EGFP+ cells were isolated
from calvarial bones by FACS and qRT-PCR was performed
using the Single Cell to CT kit (Thermo Fisher Scientific;
cat. #4458237).
Inducible Lineage-Ablation Studies during Calvarial
Development
Male Prx1-creER-EGFP+/;DTA+/ mice (3.5 weeks old; test, n = 4
mice) and Prx1-creER-EGFP/;DTA+/ mice (control, n = 7 mice)
were injected with tamoxifen (intraperitoneally, 40 mg/kg in
sterile oil) for 5 days and then aged for 2 months. Mice were
euthanized and the craniumwas removed for mCTanalysis and his-
tological processing. Calvarial measurements were taken using
AVISO 3D software (FEI North America) following methodologies
described elsewhere (Richtsmeier et al., 2000). Long bone lengths
were measured manually using a digital caliper. Methods were
repeated for ablation of pnPRX1+ cells in 7-day-old animals (test
n = 3, control n = 2).
Healing of Subcritical-Size Calvarial Defects after 2-
Month Ablation of pnPRX1+ Cells
Male Prx1-creER-EGFP+/;DTA+/ mice (3.5 weeks old; test, n = 4)
and Prx1-creER-EGFP/;DTA+/ male mice (control, n = 2) were
injected with tamoxifen (intraperitoneally, 40 mg/kg in sterile
oil) for 5 days. Sixty days later, a 0.5-mm defect was made in the
right parietal bone using a 0.5-mm round bur. Twenty-eight days
after surgery, calvarial samples were fixed in 70% EtOH for mCT
analysis and histological processing.
Comparative Localization of pnPRX1+ Cells and
pnGLI1+ Cells
Male Prx1-creER-EGFP+/;tdTOMATO+/ and Gli1-creER+/;
tdTOMATO+/ mice (3.5 weeks old) were injected with tamoxifen
(intraperitoneally, 40 mg/kg in sterile oil) for 5 consecutive days
944 Stem Cell Reports j Vol. 8 j 933–946 j April 11, 2017
(short-pulsing, n = 2). On day 6, animalswere euthanized and their
mandibles were dissected for fluorescent histological analysis.
Statistics
Statistical analysis was performed using two-tailed distribution
equal-variance Student’s t test, and results are shown as means ±
SD. Statistically significant difference is indicated in figures as
*p < 0.05 or **p < 0.01.
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